Galera Therapeutics Inc. (GRTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Galera Therapeutics Inc.

    OTC: GRTX · Real-Time Price · USD
    0.03
    0.00 (9.09%)
    At close: Apr 04, 2025, 2:24 PM

    Galera Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 3.84M 259K 114K 778K
    Gross Profit
    		 -3.84M -259K -114K -778K
    Operating Income
    		 -20.16M -46.95M -51.23M -73.37M
    Interest Income
    		 554K 9.82M 506K 32K
    Pretax Income
    		 -19.16M -59.08M -62.29M -80.53M
    Net Income
    		 -18.96M -59.08M -62.22M -87.73M
    Selling & General & Admin
    		 11M 22.84M 20.21M 20.95M
    Research & Development
    		 3.15M 24.11M 31.01M 52.42M
    Other Expenses
    		 n/a n/a -11.07M -7.17M
    Operating Expenses
    		 14.15M 46.69M 51.23M 73.37M
    Interest Expense
    		 n/a n/a 11.57M 7.19M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 18M 46.95M 51.23M 73.37M
    Income Tax Expense
    		 -203K n/a -70K 7.19M
    Shares Outstanding (Basic)
    		 54.63M 44.55M 27.09M 25.79M
    Shares Outstanding (Diluted)
    		 54.63M 44.55M 27.09M 25.79M
    EPS (Basic)
    		 -0.35 -1.33 -2.3 -3.4
    EPS (Diluted)
    		 -0.35 -1.33 -2.3 -3.4
    EBITDA
    		 -20.16M -46.69M -50.61M -72.56M
    EBIT
    		 n/a -70.5M -50.72M -73.34M
    Depreciation & Amortization
    		 n/a 259K 114K 778K

    Add to Watchlist